Chinook Therapeutics
KDNY
#4181
Rank
ยฃ2.01 B
Marketcap
ยฃ30.06
Share price
0.00%
Change (1 day)
90.51%
Change (1 year)

Revenue for Chinook Therapeutics (KDNY)

Revenue in 2023 (TTM): ยฃ4.94 Million

According to Chinook Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ4.35 Million. In 2022 the company made a revenue of ยฃ5.06 Million a decrease over the revenue in the year 2021 that were of ยฃ38.24 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Chinook Therapeutics from 2020 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) ยฃ4.94 M-2.39%
2022 ยฃ5.06 M-86.76%
2021 ยฃ38.24 M1029.84%
2020 ยฃ3.38 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA